Back

Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19) in Shanghai, China

Cao, M.; Zhang, D.; Wang, Y.; Lu, Y.; Zhu, X.; Li, Y.; Xue, H.; Lin, Y.; Zhang, M.; Sun, Y.; Yang, Z.; Shi, J.; Wang, Y.; Zhou, C.; Dong, Y.; Liu, P.; Dudek, S. M.; Xiao, Z.; Lu, H.; Peng, L.

2020-03-06 respiratory medicine
10.1101/2020.03.04.20030395 medRxiv
Show abstract

BackgroundSince mid-December 2019, a cluster of pneumonia-like diseases caused by a novel coronavirus, now designated COVID-19 by the WHO, emerged in Wuhan city and rapidly spread throughout China. Here we identify the clinical characteristics of COVID-19 in a cohort of patients in Shanghai. MethodsCases were confirmed by real-time RT-PCR and were analysed for demographic, clinical, laboratory and radiological features. ResultsOf 198 patients, the median duration from disease onset to hospital admission was 4 days. The mean age of the patients was 50.1 years, and 51.0% patients were male. The most common symptom was fever. Less than half of the patients presented with respiratory systems including cough, sputum production, itchy or sore throat, shortness of breath, and chest congestion. 5.6% patients had diarrhoea. On admission, T lymphocytes were decreased in 45.8% patients. Ground glass opacity was the most common radiological finding on chest computed tomography. 9.6% were admitted to the ICU because of the development of organ dysfunction. Compared with patients not treated in ICU, patients treated in the ICU were older, had longer waiting time to admission, fever over 38.5{degrees} C, dyspnoea, reduced T lymphocytes, elevated neutrophils and organ failure. ConclusionsIn this single centre cohort of COVID-19 patients, the most common symptom was fever, and the most common laboratory abnormality was decreased blood T cell counts. Older age, male, fever over 38.5{degrees}C, symptoms of dyspnoea, and underlying comorbidity, were the risk factors most associated with severity of disease.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 9%
19.2%
2
Virology Journal
32 papers in training set
Top 0.1%
13.4%
3
Medicine
31 papers in training set
Top 0.2%
5.7%
4
Frontiers in Medicine
120 papers in training set
Top 0.6%
4.2%
5
Scientific Reports
3612 papers in training set
Top 25%
4.2%
6
Annals of Translational Medicine
18 papers in training set
Top 0.1%
3.3%
50% of probability mass above
7
Journal of Medical Virology
140 papers in training set
Top 0.7%
3.3%
8
Journal of Clinical Virology
63 papers in training set
Top 0.2%
2.9%
9
Journal of Clinical Medicine
97 papers in training set
Top 1%
2.9%
10
BMJ Open
601 papers in training set
Top 8%
2.5%
11
Cureus
68 papers in training set
Top 2%
2.2%
12
Life
29 papers in training set
Top 0.2%
2.0%
13
BMJ Open Respiratory Research
35 papers in training set
Top 0.3%
2.0%
14
Archives of Clinical and Biomedical Research
28 papers in training set
Top 0.4%
1.8%
15
Vaccines
198 papers in training set
Top 2%
1.8%
16
Genomics
64 papers in training set
Top 1%
1.2%
17
Infection
15 papers in training set
Top 0.1%
1.2%
18
Frontiers in Immunology
638 papers in training set
Top 8%
1.1%
19
Journal of Medical Microbiology
25 papers in training set
Top 0.5%
1.1%
20
Journal of Translational Medicine
57 papers in training set
Top 1%
1.1%
21
European Respiratory Journal
59 papers in training set
Top 1.0%
1.1%
22
Open Forum Infectious Diseases
142 papers in training set
Top 2%
1.0%
23
International Journal of Infectious Diseases
129 papers in training set
Top 3%
0.9%
24
eBioMedicine
183 papers in training set
Top 6%
0.9%
25
Computers in Biology and Medicine
128 papers in training set
Top 4%
0.9%
26
Clinical Epidemiology
10 papers in training set
Top 0.3%
0.9%
27
Journal of the American Heart Association
140 papers in training set
Top 3%
0.9%
28
Biomedicine & Pharmacotherapy
42 papers in training set
Top 2%
0.6%
29
Frontiers in Molecular Biosciences
102 papers in training set
Top 3%
0.6%
30
Medical Research Archives
11 papers in training set
Top 0.6%
0.6%